MOS
RDHL

MGO One Seven’s Redhill Biopharma RDHL Stock Holding History

MGO One Seven’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-630
Closed -$5.84K – 1038
2024
Q2 		$5.84K Hold
630
– – ﹤0.01% 961
2024
Q1 		$8.35K Hold
630
– – ﹤0.01% 895
2023
Q4 		$23K Hold
630
– – ﹤0.01% 898
2023
Q3 		$8.03K Buy
630
+200
+47% +$5.23K ﹤0.01% 833
2023
Q2 		$12.9K Buy
+430
New +$24.8K ﹤0.01% 784
2023
Q1 		– Sell
-30
Closed -$4.21K – 890
2022
Q4 		$4.21K Buy
+30
New +$13K ﹤0.01% 736

Other funds holding RDHL

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MGO One Seven's RDHL Position: Q3 2024 in Review

MGO One Seven sold out of Redhill Biopharma (RDHL) in Q3 2024, closing a stake of 630 shares — an estimated $5.84K sold.

MGO One Seven first reported a position in RDHL in Q4 2022 and held it in 6 quarters. The position peaked at $23K in Q4 2023. 11 funds tracked by Wall St. Rank hold RDHL as of Q3 2024.

  • MGO One Seven reported no remaining Redhill Biopharma position as of Q3 2024 after selling out during the quarter.
  • MGO One Seven sold 630 Redhill Biopharma shares in Q3 2024, an estimated $5.84K.
  • MGO One Seven first reported a position in Redhill Biopharma in Q4 2022 and held it in 6 quarters.
  • MGO One Seven's Redhill Biopharma position peaked at $23K in Q4 2023.
  • 11 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2024.

Based on MGO One Seven's 13F filing for Q3 2024, filed 15 Oct 2024.